MEDIAN TECHNOLOGIES (ALMDT.PA) Stock Price & Overview
EPA:ALMDT • FR0011049824
Current stock price
The current stock price of ALMDT.PA is 4.44 EUR. Today ALMDT.PA is down by -2.42%. In the past month the price decreased by -16.34%. In the past year, price increased by 61.29%.
ALMDT.PA Key Statistics
- Market Cap
- 167.21M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.16
- Dividend Yield
- N/A
ALMDT.PA Stock Performance
ALMDT.PA Stock Chart
ALMDT.PA Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ALMDT.PA. When comparing the yearly performance of all stocks, ALMDT.PA is one of the better performing stocks in the market, outperforming 89.55% of all stocks.
ALMDT.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALMDT.PA. Both the profitability and financial health of ALMDT.PA have multiple concerns.
ALMDT.PA Earnings
ALMDT.PA Forecast & Estimates
11 analysts have analysed ALMDT.PA and the average price target is 12.55 EUR. This implies a price increase of 182.57% is expected in the next year compared to the current price of 4.44.
For the next year, analysts expect an EPS growth of 33.59% and a revenue growth 3.31% for ALMDT.PA
ALMDT.PA Groups
Sector & Classification
ALMDT.PA Financial Highlights
Over the last trailing twelve months ALMDT.PA reported a non-GAAP Earnings per Share(EPS) of -1.16. The EPS increased by 9.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -113.84% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALMDT.PA Ownership
ALMDT.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EQS | EQUASENS | 13.06 | 594.664M | ||
| GPI | GPI SPA | 16.7 | 476.437M | ||
| ALCGM | CEGEDIM SA | 7.77 | 174.135M | ||
| AGFB | AGFA-GEVAERT NV | 9.51 | 74.159M | ||
| AJ91 | DOCCHECK AG | N/A | 55.263M | ||
| M3V | MEVIS MEDICAL SOLUTIONS AG | N/A | 41.132M | ||
| ALINS | INTRASENSE SAS | N/A | 10.096M | ||
| MLLAB | MEDIA LAB SPA | N/A |
Related stock screener links
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About ALMDT.PA
Company Profile
MEDIAN Technologies SA engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology. The company is headquartered in Valbonne, Paca and currently employs 211 full-time employees. The company went IPO on 2011-05-20. The firm develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The firm operates one subsidiary, Median Technologies Inc, based in the United States.
Company Info
IPO: 2011-05-20
MEDIAN TECHNOLOGIES
Les Deux Arcs - Batiment B 1800, Route des Cretes
Valbonne PACA FR
Employees: 250
Phone: 33493333777
MEDIAN TECHNOLOGIES / ALMDT.PA FAQ
What does MEDIAN TECHNOLOGIES do?
MEDIAN Technologies SA engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology. The company is headquartered in Valbonne, Paca and currently employs 211 full-time employees. The company went IPO on 2011-05-20. The firm develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The firm operates one subsidiary, Median Technologies Inc, based in the United States.
Can you provide the latest stock price for MEDIAN TECHNOLOGIES?
The current stock price of ALMDT.PA is 4.44 EUR. The price decreased by -2.42% in the last trading session.
Does MEDIAN TECHNOLOGIES pay dividends?
ALMDT.PA does not pay a dividend.
How is the ChartMill rating for MEDIAN TECHNOLOGIES?
ALMDT.PA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What do analysts say about MEDIAN TECHNOLOGIES (ALMDT.PA) stock?
11 analysts have analysed ALMDT.PA and the average price target is 12.55 EUR. This implies a price increase of 182.57% is expected in the next year compared to the current price of 4.44.
Should I buy ALMDT stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALMDT.PA.
Can you provide the market cap for MEDIAN TECHNOLOGIES?
MEDIAN TECHNOLOGIES (ALMDT.PA) has a market capitalization of 167.21M EUR. This makes ALMDT.PA a Micro Cap stock.